Malacca General Hospital is a government-funded public hospital in Malacca City, Malacca, Malaysia. A secondary and specialist hospital, it serves as a referral centre for patients from primary and health centres in the state as well as the northern part of Johor and the Tampin district of Negeri Sembilan.

There are 806 beds in Hospital Melaka.

During the past decade, Hospital Melaka conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Melaka" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Hospital Sultanah Bahiyah" with 2 trials sponsored, "Baxalta now part of Shire" with 1 trials sponsored and "Hospital Raja Permaisuri Bainun" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Melaka" #1 collaborator was "Hospital Queen Elizabeth, Malaysia" with 3 trials as a collaborator, "Kuala Lumpur General Hospital" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Hospital Enche Besar Hajjah Khalsom, Kluang, Johor" with 2 trials as a collaborator and "Hospital Melaka, Melaka" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Melaka" are "Arthritis, Psoriatic" (3 trials), "Anosmia" (2 trials), "COVID-19" (2 trials), "Dysgeusia" (2 trials) and "SARS-CoV Infection" (2 trials). Many other conditions were trialed in "Hospital Melaka" in a lesser frequency.

Most popular intervention types in "Hospital Melaka" are "Drug" (6 trials), "Other" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Guselkumab" (3 trials), "Placebo" (3 trials), "Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances" (2 trials), "Empagliflozin" (1 trials) and "GerEPO" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Melaka" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Melaka". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hospital Melaka, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Melaka, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".